Axxin
Private Company
Funding information not available
Overview
Founded in 1998 and headquartered in San Diego, Axxin is a private company focused on developing and manufacturing portable, cost-effective diagnostic platforms for lateral flow and molecular assays. Its core technology, the Axxin Cubic™ platform, enables scalable, high-sensitivity handheld and benchtop readers designed to simplify point-of-care and near-patient testing. The company operates as a revenue-generating, commercial-stage business, serving diagnostic innovators with full product development and regulatory support to accelerate commercialization.
Technology Platform
Axxin Cubic™ platform: A scalable, modular system for low-cost, high-sensitivity handheld and benchtop readers capable of complex test sequences for lateral flow and molecular diagnostics.
Opportunities
Risk Factors
Competitive Landscape
Axxin competes in the diagnostic instrument space against large, diversified IVD companies (e.g., Abbott, QuidelOrtho, bioMérieux) as well as specialized point-of-care platform developers. Its differentiation lies in its focus on cost-effective, scalable, and customizable platforms coupled with hands-on regulatory and development support for partners.